We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




MRI Scans Can Predict Effects of Multiple Sclerosis Flare-Ups on Optic Nerve

By HospiMedica International staff writers
Posted on 19 Jan 2009
One of the most sinister features of multiple sclerosis (MS)--its pure unpredictability--may finally be starting to yield to sophisticated medical imaging techniques. More...


Researchers from Washington University School of Medicine in St. Louis (MO, USA) reported online on December 10, 2008, in the journal Neurology that an approach known as magnetic resonance (MR) diffusion tensor imaging (DTI) allowed them to estimate three months in advance the chronic effects of inflammation of the optic nerve. The disorder occurs most frequently as a result of MS, a neurodegenerative condition that can present with a very wide variety of symptoms that range from vision loss and other sensory damage to muscle weakness, plasticity, or paralysis to depression, sleep loss, or incontinence.

"We see this as part of a battery of tests we hope to give patients within the next decade to help our clinical assessment and tailor it to an optimal treatment,” stated lead author Robert T. Naismith, M.D., assistant professor of neurology and a staff physician at Barnes-Jewish Hospital (St. Louis, MO, USA). "It may also help further refine our basic understanding of MS in terms of expanding our insights into where and how damage occurs and why it can affect patients differently.”

Scientists believe MS results from misdirected immune system attacks against the nervous system. Symptoms occur in episodes that vary unpredictably in nature, severity, duration, and frequency. Symptoms of optic nerve inflammation, known as optic neuritis, include loss of vision, blurring, or fogginess and pain in the affected eye.

Regular MRI scans can detect optic neuritis but offer no data on its severity and potential lasting consequences for a patient's vision. Currently in use clinically to detect and follow-up on strokes, DTI uses a rapid series of MRI scans to track water diffusion in tissue. Noting that inflammation and the cell damage it causes would likely alter water diffusion in the affected tissues, Dr. Naismith and his colleagues hypothesized that this information might allow them to assess the severity and potential for lasting damage of MS flare-ups.

Over the past five years, the new study's senior authors, Sheng-Kwei Song, Ph.D., associate professor of radiology, and Anne Cross, M.D., professor of radiology, did much of the quantitative work in animal models of MS. The new data, based upon this successful collaborative history, are the first to demonstrate that DTI can produce potentially useful predictive information in humans.

For the study, researchers used DTI to image the optic nerves of 12 healthy volunteers, 12 patients who had begun to suffer from optic neuritis within the past month, and 28 patients with a history of earlier outbreaks. They gave participants with optic neuritis or a history of it, detailed assessments of their visual health, including tests of visual acuity and for the thickness and conductivity of their optic nerves.

In the healthy individuals, DTI scans showed that the water diffusion along the length of the subjects' optic nerves, a characteristic known as axial diffusivity, averaged approximately 1.66 micrometers squared per millisecond. In three patients with acute optic neuritis, those levels went down as much as 0.45 micrometers squared per millisecond.

"As the inflammation breaks down the structure of the axons or branches of the optic nerves, the normal water diffusion in this direction is impeded,” Dr. Naismith explained. "After several months, though, the debris is cleared away, and this value and another characteristic known as radial diffusivity then start to increase.”

In acute patients, the initial decrease in axial diffusivity brought on by optic neuritis correlated with decreased sensitivity to visual contrast one month and three months later. In patients with a history of optic neuritis, the increase in radial diffusivity was a good predictor of lower scores on several tests of visual health. Scientists plan to evaluate the acute patients again one year after the onset of symptoms to see if the scan results continue to be predictive.

Researchers are currently working to expand the approach to assess MS attacks in the brain and spinal cord. "The optic nerve was our proof of concept, because it's structurally a very simple tract with all the nerves going one way, like a one-way street,” Dr. Naismith conlcuded. "The next step is taking the technique into the brain and spinal cord, where there are many different streets crossing. Measuring damage and correlating it to dysfunction will be more complex as a result.”

Related Links:

Washington University School of Medicine





Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Fetal Monitor
BT-380
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.